ArticleClinical and experimental dental research2026
Impact of Thermal Treatment on Growth Factor Levels in Injectable Horizontal Platelet-Rich Fibrin: An In Vitro Study.
Article in Clinical and experimental dental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPlatelet-rich fibrin (PRF) is widely recognized for its regenerative properties in periodontal therapy, particularly through the release of endogenous growth factors. Injectable horizontal PRF (H-PRF), a recent advancement, has gained interest due to its improved cell distribution and structural integrity. The aim of this study was to analyze and compare the levels of growth factors released from injectable H-PRF subjected to different thermal treatments.
methodsVenous blood samples from 16 healthy participants (aged 18-25 years) were collected and divided into four groups: Group I (unheated control), Group II (37°C), Group III (45°C), and Group IV (60°C). Liquid H-PRF was prepared using horizontal centrifugation (700 RCF, 8 min), followed by controlled heating. Growth factor quantification was performed using the LEGENDplex Human Growth Factor Panel. Solidification and degradation profiles were also recorded. Statistical analyses included ANOVA and Bonferroni post hoc tests (significance at p < 0.05).
resultsThe solidification time decreased significantly with increasing temperature, ranging from 24 min in Group I to 5 min in Group IV. After 24 days, heated H-PRF gels (especially 45°C and 60°C) retained greater mass, indicating slower degradation. Significant intergroup differences were observed for angiopoietin-2 (p < 0.001), PDGF-AA (p = 0.002), TGF-α (p = 0.036), and VEGF (p = 0.011), with Group II showing the highest levels of angiogenic factors. No significant differences were noted for EGF, FGF-basic, HGF, and PDGF-BB.
conclusionThermal treatment of H-PRF at moderate temperatures (particularly 37°C and 45°C) enhances the release of angiogenic growth factors while improving the mechanical stability of the gel. However, the heating protocol will need to be customized based on the intended clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.